Chang, P.-H.; Chen, H.-Y.; Chang, Y.-S.; Su, P.-J.; Huang, W.-K.; Lin, C.-F.; Hsieh, J.C.-H.; Wu, C.-T.
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy. Cancers 2024, 16, 894.
https://doi.org/10.3390/cancers16050894
AMA Style
Chang P-H, Chen H-Y, Chang Y-S, Su P-J, Huang W-K, Lin C-F, Hsieh JC-H, Wu C-T.
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy. Cancers. 2024; 16(5):894.
https://doi.org/10.3390/cancers16050894
Chicago/Turabian Style
Chang, Pei-Hung, Hung-Yi Chen, Yueh-Shih Chang, Po-Jung Su, Wen-Kuan Huang, Cheng-Feng Lin, Jason Chia-Hsun Hsieh, and Chun-Te Wu.
2024. "Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy" Cancers 16, no. 5: 894.
https://doi.org/10.3390/cancers16050894
APA Style
Chang, P.-H., Chen, H.-Y., Chang, Y.-S., Su, P.-J., Huang, W.-K., Lin, C.-F., Hsieh, J. C.-H., & Wu, C.-T.
(2024). Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy. Cancers, 16(5), 894.
https://doi.org/10.3390/cancers16050894
